'Anti-aging' hormone could unlock new treatments for kidney and heart disease

February 13, 2017, King's College London
Credit: CC0 Public Domain

A new study by researchers at King's College London has found that patients with diabetes suffering from the early stages of kidney disease have a deficiency of the protective 'anti-ageing' hormone, Klotho.

The study, published today in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]), suggests that Klotho may play a significant role in the development of kidney disease, which is often prevalent in patients with diabetes.

This could mean that Klotho levels have the potential to be used as a risk marker to predict kidney disease, as well as being a target for developing new treatments to prevent kidney disease in patients with type 1 diabetes.

Previous work undertaken at King's has also shown that Klotho protects the vascular system against changes associated with abnormal ageing, such as the thickening of artery walls (atherosclerosis), which characterises age related disorders such as diabetes, heart disease and hypertension.

In this study, scientists tested blood and urine samples from 78 patients with type 1 diabetes of which 33 also showed signs of the early stages of diabetic kidney disease, called microalbuminuria.

They found that patients with microalbuminuria had lower levels of the circulating Klotho hormone, compared with patients without microalbuminuria. Klotho levels in patients without microalbuminuria were similar to levels found in healthy adults.

First author of the study, Dr Giuseppe Maltese, from the Cardiovascular Division at King's College London said: 'For the first time, Klotho has been linked to kidney disease in type 1 diabetes patients and this finding represents an exciting step towards developing new markers for disease and potentially new treatments.'

Senior author, Dr Janaka Karalliedde, said: 'With further research using larger cohorts of patients with type 1 and 2 diabetes we hope to expand the scope of this work to identify at an early stage at high risk of progression of kidney disease and cardiovascular disease.'

Dr Richard Siow, a co-author of the study, recently published research which showed the protective effects of Klotho in cardiovascular cells and said: 'This study highlights the important clinical and that is being undertaken on Klotho at King's.

'Our research will help scientists to better understand the mechanisms by which this hormone benefits healthy ageing, as well as how deficits in Klotho lead to age related diseases. We are conducting further research on the role of Klotho in ageing and longevity as part of ARK (Ageing Research at King's) research initiatives.'

Limitations of this study include its relatively small and selective sample size and the cross-sectional design, which is unable to identify a causal relationship between Klotho and development of kidney disease.

Explore further: Low levels of circulating protein linked to kidney function decline

More information: 'Peturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria' Diabetologia, 13 February 2017. DOI: 10.1007/s00125-017-4219-1

Related Stories

Low levels of circulating protein linked to kidney function decline

January 19, 2017
Higher blood levels of a protein called klotho may help preserve kidney function, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Although additional studies ...

Low levels of circulating protein linked with heart problems in mice with kidney disease

December 4, 2014
Decreased blood levels of a kidney-derived protein called Klotho increases the risk of heart disease in mice with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society ...

A new treatment for kidney disease-associated heart failure?

January 9, 2013
Chronic kidney disease (CKD) patients frequently suffer from mineral bone disorder, which causes vascular calcification and, eventually, chronic heart failure. Similar to patients with CKD, mice with low levels of the protein ...

Longevity hormone is lower in stressed and depressed women

June 16, 2015
Women under chronic stress have significantly lower levels of klotho, a hormone that regulates aging and enhances cognition, researchers at UC San Francisco have found in a study comparing mothers of children on the autism ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.